ENLV Market Cap History



Below is a table of the ENLV market cap history going back to 3/6/2019:

Date ENLV Market Cap
3/6/20194.73M
8/7/20191.23B
6/5/2019121.37M
12/31/201986.71M
12/31/2020122.98M

Also see: ENLV Shares Outstanding History
and ENLV YTD Return
ENLV Historical Market Cap:
+496.01% CAGR
ENLV Historical Market Cap: +496.01% CAGR

Mouse over chart for data details
3/6/20198/7/20196/5/201912/31/201912/31/2020
Enlivex Therapeutics is a clinical stage immunotherapy company, developing Allocetra™, a cell therapy designed to reprogram macrophages into their homeostatic state. Co. is focused on three main clinical verticals: sepsis; COVID-19; and solid tumors (the Indications). Co. is developing Allocetra™ as an adjunctive immunomodulating cell therapy for avoiding organ failure caused by sepsis. The drug would be administered intravenously to the patient following the diagnosis of sepsis in addition to standard of care treatment. Co. is also developing Allocetra™ as a solid cancer immunotherapy. We show 5 historical shares outstanding datapoints in our ENLV shares outstanding history coverage, used to compute ENLV market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ENLV market cap history over the course of time is important for investors interested in comparing ENLV's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ENLV versus a peer is one thing; comparing ENLV market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ENLV can fluctuate over the course of history. With this page we aim to empower investors researching ENLV by allowing them to research the ENLV market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ENLV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Enlivex Therapeutics (ENLV) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ENNV Market Cap History
ENOR Market Cap History
ENSC Market Cap History
ENTF Market Cap History
ENTX Market Cap History
ENVI Market Cap History
EOCW Market Cap History
EPHY Market Cap History
EPIX Market Cap History
EPRX Market Cap History
More Miscellaneous companies »

 

ENLV Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.